Validation of the Spanish version of the Rhinoconjunctivitis Quality of Life Questionnaire (RQLQ);Validación de la versión española del cuestionario de calidad de vida para pacientes con rinoconjuntivitis

Revista Clinica Espanola

Volumn 204, Issue 3, 2004, Pages 131-138

  Soler, R ^a   de la Hoz, B ^b   Badia, X ^c,d   Mercadal, J ^e   Lozano, R ^e   Benavides, A ^d   Roset, M ^d  

^a HOSPITAL SON DURETA   (Spain)

^b HOSPITAL RAMÓN Y CAJAL   (Spain)

^c HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^d Health Outcomes Research Europe   (Spain)

^e Centro de Investigaciones Farmaceuticos Grupo Ferrer   (Spain)

Author keywords

Health related quality of life; Questionnaires; Rhinoconjunctivitis; RQLQ; Validation

Indexed keywords

ANTIHISTAMINIC AGENT;

ADULT; AGE; AMBULATORY CARE; ARTICLE; CLINICAL PRACTICE; CONSTANTS AND COEFFICIENTS; CONTROLLED STUDY; CORRELATION ANALYSIS; CORRELATION COEFFICIENT; DEMOGRAPHY; FEASIBILITY STUDY; FEMALE; HEALTH CARE FACILITY; HUMAN; LANGUAGE; MAJOR CLINICAL STUDY; MALE; MEDICAL INSTRUMENTATION; MEDICAL SPECIALIST; PATIENT CARE; PERENNIAL RHINITIS; QUALITY OF LIFE; QUESTIONNAIRE; RELIABILITY; RHINOCONJUNCTIVITIS; SCORING SYSTEM; SEASONAL VARIATION; SENSITIVITY ANALYSIS; SOCIAL ASPECT; SPAIN; SYMPTOMATOLOGY; TIME; VALIDATION PROCESS;

EID: 2342430536     PISSN: 00142565     EISSN: None     Source Type: Journal    
DOI: 10.1157/13058825     Document Type: Article

References (25)

1. Aberg N, Sundell J, Eriksson B, Hesselmar B, Aberg B. Prevalence of allergic diseases in schoolchildren in relation to family history, upper respiratory tract infections, and residential characteristics. Allergy 1996;51: 232-7.
2. Sibbald B, Rink E, D'Souza M. Is the prevalence of atopy increasing? Br J Gen Pract 1990;40:338-40.
3. Wüthirch B, Schildler C, Leuenberger P, Ackermann-Liebrich U. Prevalence of atopy and pollinosis in the adult population of Switzerland (SAPALDIA study). Swiss study on air pollution and lung diseases in adults. Int Arch Allergy Immunol 1995;106:149-56.
4. Mygind N, Dahl R. Epidemiology of allergic rhinitis. Pediatr Allergy Immunol 1996;7(Suppl 9):57-62.
5. International Rhinitis Management Working Group. International concensus report on the diagnosis and management of rhinitis. Allergy 1994; 49(Suppl 9): 5-34.
6. Sibbald B, Rink E. Epidemiology of seasonal and perennial rhinitis: clinical presentation and medical history. Thorax 1991;46:859-901.
7. García-González JJ, Vega-Chicote JM, Rico P, Moscoso del Prado J, Carmona JM, Miranda A, et al. Prevalence of atopy in students from Málaga, Spain. Annals of Allergy, Asthma and Immunology 1998;80(3):237-44.
8. Van Cauwenberger P, Bachert C, Passalacqua G, Bousquet J, Canonica GW, Durham SR, et al. Declaración de consenso sobre el tratamiento de la rinitis alérgica. Academia Europea de Alergología e Inmunología Clínica. Allergy 2000; 55:116-34.
9. Bousquet J, Bullinger M, Fayol C, Marquis P, Valentín B, Burtin B. Assesment of the quality of life in patients with perennial allergic rhinitis with the French version of the SF-36 Health Status Questionnaire. J Allergy Clin Immunol 1994;94:182-8.
10. Juniper EF, Guyatt GH, Dolvich J. Assesment of quality of life in adolescents with allergic rhinoconjunctivitis: development and testing of a questionnaire for clinical trials. J Allergy Clin Immunol 1994;93:413-23.
11. Spaeth J, Klimer L, Mosges R. Sedation by allergic rhinitis is caused by the condition and not by the antihitamine treatment. Allergy 1996;51: 903-6.
12. Vuurman EF, van Veggel LM, Uiterwijk MM, Leutner D, O'Hanlon JF. Seasonal allergic rhinitis and antihistamine's effects on children's learning. Ann Allergy 1993;71:121-6.
13. Simons FE. Learning impairment and allergic rhinitis. Allergy Asthma Proc 1996;17:185-9.
14. Juniper E, Guyatt GH. Development and testing of a new measure of health status for clinical trials in rhinoconjunctivitis. Clinical and Experimental Allergy 1991;21:77-83.
15. Guyatt G, Feeny D, Patrick DL. Measuring health-related quality of life. Ann Intern Med, 1993;118:622-9.
16. Badia X, Salamero M, Alonso J, Ollé A. La medida de la salud: guía de escalas de medición en español. Barcelona: PPU; 1996.
17. Juniper EF, Guyatt GH, Griffith LE, Ferrie PJ. Interpretation of rhinoconjuntivitis quality of life questionnaire data. J Allergy Clin Immunol 1996; 98:843-5.
18. Guillemin F, Bombardier C, Beaton S. Cross-cultural adaption of health-related quality of life measures: literature review and proposed guidelines. J Clin Epidemiol 1993;12:417-32.
19. Badia X, Roset M, Monserrat S, Herdman M, Segura A. La versión española del EuroQol: descripción y aplicaciones. Med Clin 1999;112(Suppl 1): 79-85.
20. González MA, Estes KS. Pharmacokinetic overview of oral second-generation H1 antihistamines. Int J Clin Pharmacol Ther 1998;36:292-300.
21. Colton T. Estadística en medicina. Barcelona: Masson-Salvat medicina; 1979.
22. Nunnally J. Psychometric theory. 2nd ed. New York: McGraw-Hill; 1978.
23. Hays RD, Anderson R, Revicki D. Psychometric considerations in evaluating health-related quality of life masures. Qual Life Res 1993;2:441-9.
24. Casado A, Prieto L, Alonso J. El tamaño del efecto de la diferencia entre dos medidas: ¿estadísticamente significativo o clínicamente relevante? Med Clin (Barc) 1999; 112:584-8.
25. Dalfó A, Badia X, Roca-Cusachs A, Aristegui I, Roset M. Validación de cuestionario de calidad de vida en hipertensión arterial (CHAL) para su uso en España. Relación entre variables clínicas y calidad de vida. Atención Primaria 2000;26:96-103.